Rheumatoid Arthritis

Popular rheumatoid arthritis drug claims it's not just for adult conditions.

Despite claims that biologics for treating rheumatoid arthritis are highly effective, Medicaid patients seem to demonstrate low adherence.

Could telephone-based therapy management really make a difference in clinical outcomes.

A new implantable device could regenerate cartilage in joints.

FDA approved test catches novel rheumatoid arthritis markers before it's too late.

World Arthritis Day 2010 is today, so here are some arthritis health tips.

European Union okays Vimovo for osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis

This podcast offers advice on how patients can manage their arthritis and relieve their pain.

Through 2030, the prevalence of arthritis is expected to rise significantly and obesity may be a factor.

Novartis' experimental drug treats three autoimmune disorders.

This podcast discusses the difficulties associated with failing to treat RA early on.

Physical therapy may provide benefits to those suffering from Rheumatic disease, according to the American College of Rheumatology.

A phase II clinical study began for Galapagos NV's drug candidate GLPG0259, a novel drug being developed for rheumatoid arthritis.

A second biologic option is now available for patients in New Zealand with forms of arthritis.

In observance of World Arthritis Day, the Arthritis Foundation requests that all Americans "Do Blue" on Tuesday, October 12.

Syk Inhibitor R788 proven effective in treating rheumatoid arthritis.

Abatacept may not be as effective in treating systemic lupus as previously thought, according to a study in Arthritis & Rheumatism.

Treating rheumatoid arthritis with DMARDs, glucocorticoids, biologic agents, or a combination of agents reduces radiographic evidence of joint destruction.

Centocor Ortho Biotech Inc. has submitted a supplemental Biologics License Application to the FDA to expand the Simponi (golimumab) physician label.

The Arthritis Prevention, Control and Cure Act was approved by the House Energy and Commerce Committee.

A survey of rheumatologists reveals that 44% of those that expect to prescribe Genmab/GaxoSmithKline's Arzerra say they will prescribe Arzerra before Biogen Idec/Roche/Chugai/Zenyaku Kogyo's Rituxan.

Patients taking statins for lowering cholesterol may have a reduced risk of developing rheumatoid arthritis, according to a study in PLos Medicine.

This podcast reviews the myths and misunderstandings that prevent physicians from prescribing opioids to treat chronic musculoskeletal pain.

Through research, a team of scientists have isolated a molecule that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock.

Arthritis patients that are also anemic stay at hospitals longer, undergo more procedures, and have higher hospitalization costs compared to non-anemic arthritis patients, according to a study carried out in public hospitals in France.

German researchers tested three rituximab (RTX) dosing regimens and found they have similar efficacy for rheumatoid arthritis cases that no longer respond to methotrexate.

Vitamin D's interaction with our DNA was mapped by researchers at the University of Oxford, which demonstrated its influence over 200 genes.

Those with outward facing alignment-knees relatively far apart and ankles closer together have a higher risk of developing osteoarthritis, according to a study published in Annals of the Rheumatic Diseases.

The standard DAS 28 score is the factor most strongly affecting the level of rheumatoid arthritis-related disability, according to a study in the Journal of Clinical Rheumatology.